BIOTECHNOLOGY VALUE FUND L P - 30 Sep 2025 SCHEDULE 13G/A Report for SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
SABS
Shares outstanding
51,727,908 shares
Disclosed Ownership
5,167,618 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:24:25 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 6.1% 3,041,111 0 3,041,111 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 6.1% 3,041,111 0 3,041,111 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.2% 2,075,714 0 2,075,714 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.2% 2,075,714 0 2,075,714 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.09% 44,444 0 44,444 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.09% 44,444 0 44,444 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.9% 5,116,825 0 5,116,825 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 10% 5,167,618 0 5,167,618 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 10% 5,167,618 0 5,167,618 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 10% 5,167,618 0 5,167,618 /s/ Mark N. Lampert Mark N. Lampert